Cancer Services

Urogenital and Prostate Cancer

Medical Oncology clinical trials

Name: REAL PRO

Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in ELderly patients with Metastatic Castration-Resistant Prostate Cancer.

Principal Investigator: Dr Malmaruha Arasaratnam
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
External page link More information about REAL PRO

Name: DASL HiCaP

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomized phase 3 double-blind, placebo-controlled trial of adding Darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk, clinically localised prostate cancer.

Principal Investigator: Dr Craig Kukard
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
External page link More information about DASL HiCaP

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Radiation Oncology clinical trials

Name: OPTIMAL

Optimal Prostate Fractional Study

Principal Investigator: Prof Andrew Kneebone
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
External page link More Information about OPTIMAL

Back To Top